Increasingly, sponsors are turning to experts who have “been there, done that” to help them develop protocols for their CNS trials. In this wide-ranging interview, Sofija Jovic, PhD, MBA, of WCG MedAvanteProPhase, explains why this is the case. She also discusses, among other topics, how clinical trial metrics haven’t always kept pace with scientific innovation.
Request a Genetics in Clinical Trials training session
What You'll LearnMost Recent Flipbooks
WIRB-Copernicus IRB Announces New Program to Facilitate IRB Review of Research Protocols for COVID-19 (Coronavirus) Vaccines and Therapies
Basket Clinical Trial Designs The Key to Testing Innovative Therapies is Innovation in Study Design and Conduct
Driving High Performance - Shortening study start-up and optimizing revenue generation
